Advertisement
Screener

NIAGEN BIOSCIENCE, INC. (NAGE) Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period

2.5 / 5 stars · 44/89 Roast Me

NIAGEN BIOSCIENCE, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period

NIAGEN BIOSCIENCE, INC. (NAGE) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 451 shares for the 9-month period ending 2019-09-30, per its 10-Q filed 2019-11-12.

Discontinued › Shareholders' Equity › Shares Granted or Issued, Share-Based Payment Arrangement › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2019-11-12

  • NIAGEN BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2019-09-30 was 71.00 shares, a 610.00% increase year-over-year.
  • NIAGEN BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2019-06-30 was 361.00 shares, a 234.26% increase year-over-year.
  • NIAGEN BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2019-03-31 was 19.00 shares, a 533.33% increase year-over-year.
  • NIAGEN BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2018-09-30 was 10.00 shares, a 99.87% decline year-over-year.
  • NIAGEN BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2017 was 0.00 shares.
  • NIAGEN BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2016 was 0.00 shares.
  • NIAGEN BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2016 was 0.00 shares.
  • NIAGEN BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2015 was 0.00 shares.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month
2019-09-3071.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12
432.00 shares
derived: sum of 2 quarters · filed 2019-11-12
451.00 shares
10-Q · filed 2019-11-12
2019-06-30361.00 shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07
380.00 shares
10-Q · filed 2019-08-07
2019-03-3119.00 shares
10-Q · filed 2019-05-09
2018-09-3010.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07
118.00 shares
derived: sum of 2 quarters · filed 2018-11-07
121.00 shares
10-Q · filed 2018-11-07
-41.24K shares
derived: sum of 4 quarters · filed 2018-11-07
2018-06-30108.00 shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09
111.00 shares
10-Q · filed 2018-08-09
-41.25K shares
derived: sum of 3 quarters · filed 2018-08-09
-33.31K shares
derived: sum of 4 quarters · filed 2018-08-09
2018-03-313.00 shares
10-Q · filed 2018-05-10
-41.35K shares
derived: sum of 2 quarters · filed 2018-05-10
-33.42K shares
derived: sum of 3 quarters · filed 2018-05-10
-3.27K shares
derived: sum of 4 quarters · filed 2018-05-10
2017-12-30-41.36K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15
-33.42K shares
derived: sum of 2 quarters · filed 2018-03-15
-3.27K shares
derived: sum of 3 quarters · filed 2018-03-15
0.00 shares
10-K · filed 2018-03-15
2017-09-307.94K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09
38.09K shares
derived: sum of 2 quarters · filed 2017-11-09
41.36K shares
10-Q · filed 2017-11-09
-285.31K shares
derived: sum of 4 quarters · filed 2018-03-15
2017-07-0130.15K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10
33.42K shares
10-Q · filed 2017-08-10
-293.24K shares
derived: sum of 3 quarters · filed 2018-03-15
71.12K shares
derived: sum of 4 quarters · filed 2018-03-15
2017-04-013.27K shares
10-Q · filed 2017-05-11
-323.39K shares
derived: sum of 2 quarters · filed 2018-03-15
40.97K shares
derived: sum of 3 quarters · filed 2018-03-15
2016-12-31-326.66K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15
37.70K shares
derived: sum of 2 quarters · filed 2018-03-15
0.00 shares
10-K · filed 2018-03-15
2016-10-01364.36K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10
326.66K shares
10-Q · filed 2016-11-10
2016-07-02-37.70K shares
10-Q · filed 2016-08-11
2016-01-020.00 shares
10-K · filed 2018-03-15
2015-01-030.00 shares
10-K · filed 2017-03-16

Similar stocks

Stock NameCountryMarket CapPE Ratio
USANA HEALTH SCIENCES INC (USNA)United States$0.264B-17.90
FITLIFE BRANDS, INC. (FTLF)United States$0.087B16.59
Canopy Growth Corp (CGC)$0.395B
MANNATECH INC (MTEX)United States$0.014B
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII)United States$0.011B-1.16
Synergy CHC Corp. (SNYR)United States$0.001B
Functional Brands Inc. (MEHA)United States$0.001B
Tilray Brands, Inc. (TLRY)United States$0.554B-5.97
Cronos Group Inc. (CRON)$1.223B
Definium Therapeutics, Inc. (DFTX)United States$4.931B-17.87